Plasma fibronectin deficiency often exists in septic surgical, trauma and burn patients with altered lung vascular permeability. This plasma fibronectin (Fn) deficiency may contribute to the etiology of decreased endothelial integrity and pulmonary edema. Plasma Fn incorporates into the extracellular matrix (ECM) of the lung where it influences cell-matrix interactions and endothelial protein permeability, in part, by its interaction with endothelial cell surface integrins. The investigators have demonstrated that infusion of purified human plasma Fn into sheep followed by its incorporation into the lung ECM prior to post- operative gram negative i.v. bacterial challenge will prevent the increase in lung protein permeability. The is vivo observation could also be """"""""modeled"""""""" in vitro using confluent lung endothelial cell monolayers treated with TNF, which results in an increase in protein permeability and a disruption of the Fn containing matrix. Addition of purified human Fn to the medium could also prevent the TNF-alpha induced increase in endothelial monolayer permeability similar to the in vivo response, if the added plasma Fn incorporates into the subendothelial matrix. The investigators hypothesize that the TNF- alpha induced increase in lung permeability is mediated by either decreased expression of a5b1 Fn integrins on endothelial cells an/or disruption of the Fn matrix due to protease release from endothelial cells. It is also hypothesized that the protective and potentially therapeutic effects of Fn on lung endothelial permeability is due to its rapid incorporation into the ECM where it provides additional RGD cell attachment sites, improves endothelial adhesion, and influences endothelial cell spreading via an integrin-mediated signal transduction process. It is proposed to use the lung lymph fistula model in sheep to determine if the increase in lung endothelial permeability caused by post-operative bacteremia can be reversed by infusion of purified PFN; and the in vitro bovine lung endothelial cell monolayer model to define the mechanism of the TNF-alpha induced increase in protein permeability. The investigators will also determine if reversal of the increased permeability accomplished by the ECM incorporation of human plasma Fn requires an integrin mediated signal transduction event triggered by a reestablished association of a5b1 integrins with human Fn incorporated into the matrix. Determining the mechanism by which plasma Fn incorporation into the lung matrix influences its vascular integrity offers a basis for developing a novel approach to treat lung vascular failure and pulmonary edema in septic surgical and trauma patients.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
5R01GM021447-25
Application #
6179847
Study Section
Surgery, Anesthesiology and Trauma Study Section (SAT)
Program Officer
Somers, Scott D
Project Start
1997-07-01
Project End
2002-05-02
Budget Start
2000-07-01
Budget End
2002-05-02
Support Year
25
Fiscal Year
2000
Total Cost
$237,512
Indirect Cost
Name
Albany Medical College
Department
Physiology
Type
Schools of Medicine
DUNS #
190592162
City
Albany
State
NY
Country
United States
Zip Code
12208
Rotundo, Robert F; Curtis, Theresa M; Shah, Melissa D et al. (2002) TNF-alpha disruption of lung endothelial integrity: reduced integrin mediated adhesion to fibronectin. Am J Physiol Lung Cell Mol Physiol 282:L316-29
Gao, Baochong; Saba, Thomas M; Tsan, Min-Fu (2002) Role of alpha(v)beta(3)-integrin in TNF-alpha-induced endothelial cell migration. Am J Physiol Cell Physiol 283:C1196-205
Chen, R; Gao, B; Huang, C et al. (2000) Transglutaminase-mediated fibronectin multimerization in lung endothelial matrix in response to TNF-alpha. Am J Physiol Lung Cell Mol Physiol 279:L161-74
Gao, B; Curtis, T M; Blumenstock, F A et al. (2000) Increased recycling of (alpha)5(beta)1 integrins by lung endothelial cells in response to tumor necrosis factor. J Cell Sci 113 Pt 2:247-57
Resnikoff, M; Brien, T; Vincent, P A et al. (1999) Lung matrix incorporation of plasma fibronectin reduces vascular permeability in postsurgical bacteremia. Am J Physiol 277:L749-59
Rotundo, R F; Vincent, P A; McKeown-Longo, P J et al. (1999) Hepatic fibronectin matrix turnover in rats: involvement of the asialoglycoprotein receptor. Am J Physiol 277:G1189-99
Curtis, T M; Rotundo, R F; Vincent, P A et al. (1998) TNF-alpha-induced matrix Fn disruption and decreased endothelial integrity are independent of Fn proteolysis. Am J Physiol 275:L126-38
Brien, T P; Reddy, P P; Vincent, P A et al. (1998) Lung matrix deposition of normal and alkylated plasma fibronectin: response to postsurgical sepsis. Am J Physiol 274:L432-43
Rotundo, R F; Rebres, R A; Mckeown-Longo, P J et al. (1998) Circulating cellular fibronectin may be a natural ligand for the hepatic asialoglycoprotein receptor: possible pathway for fibronectin deposition and turnover in the rat liver. Hepatology 28:475-85
Rebres, R A; Cho, E; Rotundo, R F et al. (1996) Reduced in vivo plasma fibronectin content of lung matrix during postoperative sepsis. Am J Physiol 271:L409-18

Showing the most recent 10 out of 58 publications